| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000031596 |
| Receipt No. | R000036073 |
| Official scientific title of the study | Pilot study of the effect of test drink in subjects with postprandial hyperglycemia. |
| Date of disclosure of the study information | 2018/03/05 |
| Last modified on | 2018/09/12 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Pilot study of the effect of test drink in subjects with postprandial hyperglycemia. | |
| Title of the study (Brief title) | Examination of inhibitory effect of test drink on postprandial hyperglycemia. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Examination of inhibitory effect of test drink containing plant extract on increase of postprandial blood glucose level. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Postprandial blood glucose level, change of blood glucose level |
| Key secondary outcomes | Area under the curve of blood glucose level, maximum blood glucose level |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of water (single ingestion) - washout period - beverage containing plant extract (single ingestion) | |
| Interventions/Control_2 | Intake of beverage containing plant extract (single ingestion) - washout period - water (single ingestion) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy males and females from 20 to 64 years of age
2) Blood glucose level at postprandial 30 minitues is ranged from 130 mg/dL to 199 mg/dL 3) Priority is given to those with a blood glucose peak of 30 minutes |
|||
| Key exclusion criteria | 1) Subjects who routinely use health food containing large amount of participating component or health food for diet
2) Subjects routinely taking medicine or health food which may influence glucose metabolism 3) Subjects who have body mass index (BMI) less than 18.5 kg/square meter or more than 30.0 kg/square meter 4) Subjects who have fasting blood glucose more than 126 mg/dL on preliminary examination 5) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) 6) Subjects having possibilities for emerging allergy related to the current study 7) Subjects who are under medication or having a history of serious diseases for which medication was required 8) Subjects who are judged as unsuitable for the current study based on the results of clinical and physical preliminary examination 9) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study 10) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating 11) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire 12) Subjects judged as unsuitable for the study by the investigator for other reasons |
|||
| Target sample size | 24 | |||
| Research contact person | |
| Name of lead principal investigator | Hirona Miura |
| Organization | Higashi shinjuku Clinic |
| Division name | Director |
| Address | 1-11-3 Okubo Shinjuku-ku Tokyo |
| TEL | 03-6233-8581 |
| koike@meiseikai-cl.com | |
| Public contact | |
| Name of contact person | Shinsuke Tsuji |
| Organization | TTC Co., Ltd. |
| Division name | Clinical Research Planning Department |
| Address | Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo |
| TEL | 03-5459-5329 |
| Homepage URL | |
| s.tsuji@ttc-tokyo.co.jp | |
| Sponsor | |
| Institute | TTC Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | non-disclosure |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | Twenty - four adult men and women with high blood glucose levels 30 minutes after a meal were given a single drink containing a plant extract and water, and the effect of suppressing an increase in postprandial blood glucose level was examined.
As a result, no significant difference was found between the botanical extract-containing beverage and the water in both the primary evaluation item and the secondary evaluation item. Regarding safety, there were no adverse events in any of the subjects during this study, and there were no problems with safety. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036073 |